Managing Associate
Washington, D.C.
Megan McKnelly advises life sciences and tech clients on strategic domestic and cross-border transactions.
Megan regularly drafts and negotiates complex collaboration and license agreements for the development of novel therapeutics and treatments, as well as research and data use agreements applying software and artificial intelligence technologies to healthcare.
Megan draws on her experience spanning diverse technology sectors—including life sciences (biotechnology, pharmaceuticals, medical devices, and digital health), AI, the Internet of Things, telecommunications, FinTech, cybersecurity, and cloud computing—to counsel clients of all sizes in shaping their IP protection and commercialization strategies.
She also conducts IP diligence for venture capital financings and tech-driven sell-side and buy-side mergers and acquisitions.